Articaine Injection, Solution
Product Images NDC 51004-0102

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Articaine (NDC 51004-0102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novocol Pharmaceutical Of Canada, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1.7 mL Cartridge Carton)

Packaging label for Articaine injection, solution containing Articaine HCl 4% (40 mg/mL) and Epinephrine 1:200,000. The box includes branding for Quala Dental Products and states the product is for human prescription use with submucosal route. It also notes the package contains 50 single-dose cartridges of 1.7 mL each, made by Novocol Pharmaceutical of Canada, Inc.*

FDA Label Image

Structural Formula (Articaine HCl)

Chemical structure diagram of articaine hydrochloride showing its molecular configuration including the thiophene ring and various functional groups relevant to this active ingredient.*

FDA Label Image

Structural Formula (Epinephrine Bitartrate)

Chemical structure diagram showing the molecular structures of Articaine Hydrochloride and Epinephrine, the active ingredients in the ARTICAINE injection solution for submucosal use by Novocol Pharmaceutical of Canada, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.